Simulations Plus’ (SLP) Outperform Rating Reaffirmed at William Blair

William Blair reissued their outperform rating on shares of Simulations Plus (NASDAQ:SLP) in a report published on Wednesday,Benzinga reports. William Blair also issued estimates for Simulations Plus’ Q1 2025 earnings at $0.16 EPS, Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at $1.12 EPS, Q1 2026 earnings at $0.19 EPS, Q2 2026 earnings at $0.35 EPS, Q3 2026 earnings at $0.40 EPS, Q4 2026 earnings at $0.45 EPS and FY2026 earnings at $1.39 EPS.

A number of other research analysts also recently issued reports on the stock. JMP Securities started coverage on shares of Simulations Plus in a research report on Tuesday, July 16th. They set a “market perform” rating on the stock. BTIG Research reduced their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. Finally, KeyCorp assumed coverage on Simulations Plus in a report on Monday, July 29th. They set an “overweight” rating and a $47.00 target price on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $54.50.

Simulations Plus Trading Down 0.4 %

SLP stock opened at $30.59 on Wednesday. The stock has a market capitalization of $613.85 million, a price-to-earnings ratio of 62.43 and a beta of 0.71. The firm’s 50-day moving average price is $31.60 and its two-hundred day moving average price is $39.40. Simulations Plus has a 12-month low of $27.22 and a 12-month high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. During the same quarter in the previous year, the business earned $0.18 EPS. Simulations Plus’s revenue was up 19.9% compared to the same quarter last year. Equities analysts predict that Simulations Plus will post 1.11 EPS for the current year.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $27.66, for a total value of $553,200.00. Following the sale, the director now directly owns 3,462,584 shares of the company’s stock, valued at $95,775,073.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Over the last quarter, insiders sold 60,750 shares of company stock valued at $1,905,655. Corporate insiders own 20.90% of the company’s stock.

Hedge Funds Weigh In On Simulations Plus

Several large investors have recently modified their holdings of SLP. Allspring Global Investments Holdings LLC bought a new stake in Simulations Plus during the 1st quarter valued at about $70,000. BNP Paribas Financial Markets increased its position in shares of Simulations Plus by 9.1% during the first quarter. BNP Paribas Financial Markets now owns 14,143 shares of the technology company’s stock valued at $582,000 after acquiring an additional 1,174 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Simulations Plus during the first quarter valued at approximately $208,000. Vanguard Group Inc. raised its holdings in Simulations Plus by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company’s stock worth $46,710,000 after acquiring an additional 12,636 shares during the last quarter. Finally, EntryPoint Capital LLC bought a new position in Simulations Plus in the 1st quarter valued at approximately $57,000. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.